See more : Li Kang Biomedical Co., Ltd. (6242.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Westlake Chemical Partners LP (WLKP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Westlake Chemical Partners LP, a leading company in the Chemicals industry within the Basic Materials sector.
You may be interested
- Rockwell Automation, Inc. (RWL.DE) Income Statement Analysis – Financial Results
- Sydinvest HøjrenteLande (SYIHYADKK.CO) Income Statement Analysis – Financial Results
- KPa-BM Holdings Limited (2663.HK) Income Statement Analysis – Financial Results
- Plaza Centers N.V. (PLAZ-L.TA) Income Statement Analysis – Financial Results
- Scan-D Corporation (6195.TWO) Income Statement Analysis – Financial Results
Westlake Chemical Partners LP (WLKP)
About Westlake Chemical Partners LP
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was incorporated in 2014 and is headquartered in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19B | 1.59B | 1.21B | 966.67M | 1.09B | 1.29B | 1.17B | 986.74M | 1.01B | 1.75B | 2.13B | 2.25B | 2.25B |
| Cost of Revenue | 803.33M | 1.22B | 773.15M | 587.79M | 712.44M | 908.46M | 769.31M | 595.41M | 624.34M | 1.00B | 1.26B | 1.61B | 1.84B |
| Gross Profit | 387.46M | 377.37M | 441.71M | 378.88M | 379.43M | 377.16M | 403.67M | 391.33M | 382.88M | 745.81M | 872.61M | 635.65M | 409.10M |
| Gross Profit Ratio | 32.54% | 23.69% | 36.36% | 39.19% | 34.75% | 29.34% | 34.41% | 39.66% | 38.01% | 42.63% | 41.01% | 28.26% | 18.17% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 27.09M | 26.62M | 28.58M | 22.16M | 26.95M | 24.62M | 27.26M | 21.97M | 20.68M | 21.30M | 24.05M | 22.49M | 0.00 |
| Selling & Marketing | 2.67M | 3.06M | 2.44M | 3.73M | 2.33M | 2.97M | 2.00M | 2.92M | 2.87M | 7.95M | 1.40M | 1.62M | 0.00 |
| SG&A | 29.75M | 29.68M | 31.02M | 25.90M | 29.28M | 27.59M | 29.26M | 24.89M | 23.55M | 29.26M | 25.45M | 24.10M | 24.31M |
| Other Expenses | 0.00 | 1.57M | 62.00K | 733.00K | 3.10M | 2.46M | 1.79M | 601.00K | 160.00K | 3.15M | 7.70M | 4.19M | 2.80M |
| Operating Expenses | 29.75M | 29.68M | 31.02M | 25.90M | 29.28M | 27.59M | 29.26M | 24.89M | 23.55M | 29.26M | 25.45M | 24.10M | 24.31M |
| Cost & Expenses | 833.08M | 1.25B | 804.17M | 613.68M | 741.72M | 936.05M | 798.57M | 620.29M | 647.89M | 1.03B | 1.28B | 1.64B | 1.87B |
| Interest Income | 0.00 | 13.41M | 8.82M | 12.04M | 19.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 26.50M | 13.41M | 8.82M | 12.04M | 19.62M | 21.43M | 21.86M | 12.61M | 4.97M | 10.50M | 8.03M | 8.94M | 8.95M |
| Depreciation & Amortization | 110.20M | 121.07M | 108.81M | 103.15M | 107.32M | 108.84M | 113.99M | 98.21M | 81.21M | 77.61M | 73.46M | 64.26M | 57.19M |
| EBITDA | 472.14M | 470.33M | 519.56M | 456.88M | 460.57M | 460.87M | 490.18M | 464.92M | 440.51M | 797.32M | 928.32M | 679.99M | 444.78M |
| EBITDA Ratio | 39.65% | 29.52% | 42.77% | 47.26% | 42.18% | 35.85% | 41.79% | 47.15% | 43.75% | 45.57% | 43.63% | 30.23% | 19.76% |
| Operating Income | 357.71M | 347.69M | 410.69M | 352.99M | 350.15M | 349.57M | 374.41M | 366.44M | 359.33M | 716.56M | 847.16M | 611.55M | 384.79M |
| Operating Income Ratio | 30.04% | 21.82% | 33.81% | 36.52% | 32.07% | 27.19% | 31.92% | 37.14% | 35.68% | 40.95% | 39.81% | 27.19% | 17.09% |
| Total Other Income/Expenses | -22.27M | -11.84M | -8.75M | -11.31M | -16.53M | -18.98M | -20.07M | -12.01M | -4.81M | -7.35M | -331.00K | -4.75M | -6.14M |
| Income Before Tax | 335.44M | 335.85M | 401.93M | 341.68M | 333.62M | 330.59M | 354.34M | 354.44M | 354.53M | 709.21M | 846.83M | 606.80M | 378.64M |
| Income Before Tax Ratio | 28.17% | 21.08% | 33.08% | 35.35% | 30.56% | 25.71% | 30.21% | 35.92% | 35.20% | 40.53% | 39.80% | 26.98% | 16.82% |
| Income Tax Expense | 813.00K | 1.02M | 549.00K | 564.00K | 728.00K | 22.00K | 1.28M | 1.04M | 672.00K | 199.39M | 300.28M | 210.88M | 131.67M |
| Net Income | 54.28M | 334.83M | 401.39M | 341.12M | 332.90M | 49.35M | 48.67M | 40.94M | 39.83M | 13.58M | 546.55M | 395.92M | 246.97M |
| Net Income Ratio | 4.56% | 21.02% | 33.04% | 35.29% | 30.49% | 3.84% | 4.15% | 4.15% | 3.95% | 0.78% | 25.69% | 17.60% | 10.97% |
| EPS | 1.54 | 9.51 | 11.40 | 9.69 | 9.65 | 1.53 | 1.72 | 1.50 | 1.47 | 0.50 | 21.54 | 15.60 | 9.73 |
| EPS Diluted | 1.54 | 9.51 | 11.40 | 9.69 | 9.65 | 1.51 | 1.72 | 1.50 | 1.47 | 0.50 | 21.54 | 15.60 | 9.73 |
| Weighted Avg Shares Out | 35.22M | 35.22M | 35.21M | 35.20M | 34.49M | 32.24M | 28.39M | 27.06M | 27.06M | 27.06M | 25.37M | 25.37M | 25.37M |
| Weighted Avg Shares Out (Dil) | 35.22M | 35.22M | 35.21M | 35.20M | 34.49M | 32.68M | 28.39M | 27.29M | 27.10M | 27.06M | 25.37M | 25.37M | 25.37M |
Westlake Chemical Partners LP Common Units (WLKP) Q3 2024 Earnings Call Transcript
Westlake Chemical Partners LP Common Units (NYSE:WLKP ) Q3 2024 Earnings Conference Call November 5, 2024 1:00 PM ET Company Participants John Zoeller - Vice President & Treasurer Jean-Marc Gilson - President & Chief Executive Officer Steve Bender - Executive...
Westlake Chemical Partners LP Announces Third Quarter 2024 Results
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2024 of $18.1 million, or $0.51 per limited partner unit, an increase of $4.9 million compared to the...
Westlake Chemical Partners LP Announces Third Quarter 2024 Distribution
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 41st quarterly distribution announced by the Partnership...
Westlake Chemical Partners LP (WLKP) Q2 2024 Earnings Call Transcript
Westlake Chemical Partners LP (NYSE:WLKP ) Q2 2024 Earnings Conference Call August 6, 2024 1:00 PM ET Company Participants John Zoeller - VP and Treasurer Albert Chao - Executive Chairman Jean-Marc Gilson - President and CEO Steve Bender - EVP...
Westlake Chemical Partners LP Announces Second Quarter 2024 Distribution
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 40th quarterly distribution announced by the Partnership...
Westlake Chemical Partners Provides Tax Reporting Information
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners (NYSE: WLKP) today provided the following information regarding 2023 investor tax reporting: As previously noted in the 2023 Investor Tax Reporting Package for our unitholders' investment in Westlake Chemical Partners, LP, the Partnership will report items...
For $10,000 in Passive Income, Invest $7,500 in These 12 Dividend Stocks
One way for investors to work smarter, not harder, is with passive income.
Westlake Chemical Partners LP (WLKP) Q1 2024 Earnings Call Transcript
Westlake Chemical Partners LP (NYSE:WLKP ) Q1 2024 Earnings Conference Call May 1, 2024 1:00 PM ET Company Participants John Zoeller - Vice President and Treasurer Albert Chao - President and Chief Executive Officer Steve Bender - Executive Vice President...
Westlake Chemical Partners LP Announces First Quarter 2024 Results
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the first quarter of 2024 of $14.8 million, or $0.42 per limited partner unit, which was in-line with first quarter 2023 net...
Westlake Chemical Partners LP Announces First Quarter 2024 Distribution
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 39th quarterly distribution announced by the Partnership...
Source: https://incomestatements.info
Category: Stock Reports